Clinical trials
Triple Negative Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
639 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 10 |
| 2010 | 21 |
| 2011 | 16 |
| 2012 | 14 |
| 2013 | 14 |
| 2014 | 18 |
| 2015 | 36 |
| 2016 | 36 |
| 2017 | 62 |
| 2018 | 48 |
| 2019 | 54 |
| 2020 | 42 |
| 2021 | 49 |
| 2022 | 45 |
| 2023 | 34 |
| 2024 | 44 |
| 2025 | 47 |
| 2026 | 37 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 212 |
| Recruiting | 148 |
| Terminated | 122 |
| Active, not recruiting | 94 |
| Withdrawn | 20 |
| Unknown status | 19 |
| Not yet recruiting | 13 |
| Suspended | 7 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 40 |
| M.D. Anderson Cancer Center | 27 |
| Novartis Pharmaceuticals | 18 |
| City of Hope Medical Center | 11 |
| Pfizer | 11 |
| AstraZeneca | 10 |
| Memorial Sloan Kettering Cancer Center | 10 |
| Merck Sharp & Dohme LLC | 10 |
| AbbVie | 9 |
| H. Lee Moffitt Cancer Center and Research Institute | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 639 |
| Breast Neoplasms | 286 |
| Carcinoma, Non-Small-Cell Lung | 162 |
| Ovarian Neoplasms | 108 |
| Squamous Cell Carcinoma of Head and Neck | 84 |
| Melanoma | 71 |
| Colorectal Neoplasms | 69 |
| Carcinoma, Renal Cell | 68 |
| Neoplasm Metastasis | 67 |
| Endometrial Neoplasms | 63 |
Trials
Showing 1 to 25 of 639. Each trial links to its page on Pharma Observatory.
539 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.